| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.32 | 3e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |